Clinical Trials
3 trialsNCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
NCT07185503 2025-09-22
Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety
Institute of Hematology & Blood Diseases Hospital, China
Recruiting
NCT05925660 2023-12-05
MUCOPS
Universitaire Ziekenhuizen KU Leuven
Phase NA Unknown